Tech Company Financing Transactions
X-Body Funding Round
On 11/8/2011, X-Body raised $3.5 million in investment from private investors.
Transaction Overview
Company Name
Announced On
11/8/2011
Transaction Type
Venture Equity
Amount
$3,545,000
Round
Undisclosed
Investors
Proceeds Purpose
The bulk of the new financing would go toward an internal treatment being developed for macular degeneration.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
307 Westlake Ave. N. 300
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Overview
The company's mission is to apply its innovative capabilities to the discovery of human antibodies against high-value therapeutic targets. X-BODY has entered into a number of alliances with other corporations to generate antibody therapeutic candidates.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hans Bishop
Chief Medical Officer
Mark Gilbert
Chief Scientific Officer
Hyam Levitsky
Chief Technical Officer
Steve Harr
VP - Manufacturing
Andy Walker
Browse more venture capital transactions:
Prev: 11/7/2011: Oclaro venture capital transaction
Next: 11/8/2011: SoundTracking venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs